4,5,6,7-TETRACHLOROPHTHALIDE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	NMWKWBPNKPGATC-UHFFFAOYSA-N
Smiles	Clc1c(Cl)c(Cl)c2C(=O)OCc2c1Cl
InChI	InChI=1S/C8H2Cl4O2/c9-4-2-1-14-8(13)3(2)5(10)7(12)6(4)11/h1H2

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C8H2Cl4O2
Molecular Weight	271.91
AlogP	4.1
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	0.0
Polar Surface Area	26.3
Molecular species	None
Aromatic Rings	1.0
Heavy Atoms	14.0

Assay Description	Organism	Bioactivity
Fungicidal activity against Magnaporthe grisea in rice plant assessed as rice blast disease measured as damage under greenhouse at 25 ppm for 8 days by foliar spray compound treated before inoculation	Magnaporthe grisea	4.0 %
Fungicidal activity against Magnaporthe grisea in rice plant assessed as rice blast disease measured as damage under greenhouse at 6.3 ppm for 8 days by foliar spray compound treated before inoculation	Magnaporthe grisea	1.0 %
Fungicidal activity against Magnaporthe grisea in rice plant assessed as rice blast disease measured as damage under greenhouse at 1.6 ppm for 8 days by foliar spray compound treated before inoculation	Magnaporthe grisea	0.0 %
Fungicidal activity against Magnaporthe grisea in rice plant assessed as rice blast disease measured as damage under greenhouse at 0.4 ppm for 8 days by foliar spray compound treated before inoculation	Magnaporthe grisea	0.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL357452
PDB	PHH
PubChem	33791
SureChEMBL	SCHEMBL27454
ZINC	ZINC02012697

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).